Initiation of highly active antiretroviral therapy in HIV-infected people has previously been proven to improve lipid levels compared to pretreatment levels, and dyslipidemia connected with HAART has also been shown to increase CVD risk, notice Robert Kaplan and co-workers. Related StoriesStudy: Safe spaces may play critical part in community-based HIV prevention effortsNegative influence of high-fat diet on red blood cells may promote development of cardiovascular diseasePitt Public Health launches study to promote wellness among aging gay and bisexual guys with HIVAs reported in Atherosclerosis, the group studied the association of lipid amounts with subclinical atherosclerosis in a study of 1827 women who participated in the ladies Interagency HIV Study.Chikungunya continues to be a major threat to public health all over the world. Related StoriesCamels in Kenya contaminated by MERS virus, brand-new research findsJohns Hopkins doctors desire people to obtain vaccinated against influenza virusOncolytic viral therapy accepted in the U.S. For use against late-stage melanomaA UTMB group previously discovered that a lately emerged lineage strain of the chikungunya virus has adapted itself to be hosted by not merely the Aedes aegypti mosquito that lives generally in the tropics but also to the Asian tiger mosquito, A. Albopictus, which can be found on all continents except Antarctica currently. This mutation in the Indian Ocean lineage occurred through a single adaptive switch in the virus' genetic code that alters one protein in the envelope surrounding the virus.